X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells

被引:391
作者
Parolini, S
Bottino, C
Falco, M
Augugliaro, R
Giliani, S
Franceschini, R
Ochs, HD
Wolf, H
Bonnefoy, JY
Biassoni, R
Moretta, L
Notarangelo, LD
Moretta, A
机构
[1] Univ Genoa, Dipartimento Med Sperimentale, Sez Istol, I-16132 Genoa, Italy
[2] Univ Brescia, Dipartimento Sci Biomed & Biotecnol, I-25123 Brescia, Italy
[3] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[4] Univ Brescia, Pediat Clin, Ist Med Mol Angelo Nocivelli, I-25123 Brescia, Italy
[5] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[6] Univ Vienna, Dept Immunol, A-1090 Vienna, Austria
[7] Ctr Immunol Pierre Fabre, F-74164 St Julien En Genevois, France
关键词
X-linked lymphoproliferative disease; Epstein-Barr virus infection; natural killer cell; natural cytotoxicity receptor; 2B4; molecule;
D O I
10.1084/jem.192.3.337
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
2B4 is a surface molecule involved in activation of the natural killer (NK) cell-mediated cytotoxicity. It binds a protein termed Src homology 2 domain-containing protein (SH2D1A) or signaling lymphocyte activation molecule (SLAM)-associated protein (SAP), which in rum has been proposed to function as a regulator of the 2B4-associated signal transduction pathway. In this study, we analyzed patients with X-linked lymphoproliferative disease (XLP), a severe inherited immunodeficiency characterized by critical mutations in the SH2D1A gene and by the inability to control Epstein-Barr Virus (EBV) infections. We show that, in these patients, 2B4 not only fails to transduce triggering signals, but also mediates a sharp inhibition of the NK-mediated cytolysis. Other receptors involved in NK cell triggering, including CD16, NKp46, NKp44, and NKp30, displayed a normal functional capability. However, their activating function was inhibited upon engagement of 2B4 molecules. CD48, the natural ligand of 2B4, is highly expressed on the surface of EBV+ B cell, lines. Remarkably, NK cells from XLP patients could not kill EBV+ B cell lines. This failure was found to be the consequence of inhibitory signals generated by the interaction between 2B4 and CD48, as the antibody-mediated disruption of the 2B4-CD48 interaction restored lysis of EBV+ target cells lacking human histocompatibility leukocyte antigen (HLA) class I molecules. In the case of autologous or allogeneic (HLA class I+) EBV+ lymphoblastoid cell lines, restoration of lysis was achieved only by the simultaneous disruption of 2B4-CD48 and NK receptor-HLA class I interactions. Molecular analysis revealed that 2B4 molecules isolated from either XLP or normal NK cells were identical. As expected, in XLP-NK cells, 2B4 did not associate with SH2D1A, whereas similar to 2B4 molecules isolated from normal NK cells, it did associate with Src homology 2 domain-containing phosphatase 1.
引用
收藏
页码:337 / 346
页数:10
相关论文
共 42 条
  • [1] Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4
    Boles, KS
    Nakajima, H
    Colonna, M
    Chuang, SS
    Stepp, SE
    Bennett, M
    Kumar, V
    Mathew, PA
    [J]. TISSUE ANTIGENS, 1999, 54 (01): : 27 - 34
  • [2] BOLHUIS RLH, 1986, J IMMUNOL, V136, P3939
  • [3] The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering
    Bottino, C
    Biassoni, R
    Millo, R
    Moretta, L
    Moretta, A
    [J]. HUMAN IMMUNOLOGY, 2000, 61 (01) : 1 - 6
  • [4] 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48
    Brown, MH
    Boles, K
    van der Merwe, PA
    Kumar, V
    Mathew, PA
    Barclay, AN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) : 2083 - 2090
  • [5] Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO
  • [6] 2-L
  • [7] NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
    Cantoni, C
    Bottino, C
    Vitale, M
    Pessino, A
    Augugliaro, R
    Malaspina, A
    Parolini, S
    Moretta, L
    Moretta, A
    Biassoni, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) : 787 - 795
  • [8] SELF CLASS-I MOLECULES PROTECT NORMAL-CELLS FROM LYSIS MEDIATED BY AUTOLOGOUS NATURAL-KILLER-CELLS
    CICCONE, E
    PENDE, D
    VITALE, M
    NANNI, L
    DIDONATO, C
    BOTTINO, C
    MORELLI, L
    VIALE, O
    AMOROSO, A
    MORETTA, A
    MORETTA, L
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (04) : 1003 - 1006
  • [9] A NOVEL RECEPTOR INVOLVED IN T-CELL ACTIVATION
    COCKS, BG
    CHANG, CCJ
    CARBALLIDO, JM
    YSSEL, H
    DEVRIES, JE
    AVERSA, G
    [J]. NATURE, 1995, 376 (6537) : 260 - 263
  • [10] Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
    Coffey, AJ
    Brooksbank, RA
    Brandau, O
    Oohashi, T
    Howell, GR
    Bye, JM
    Cahn, AP
    Durham, J
    Heath, P
    Wray, P
    Pavitt, R
    Wilkinson, J
    Leversha, M
    Huckle, E
    Shaw-Smith, CJ
    Dunham, A
    Rhodes, S
    Schuster, V
    Porta, G
    Yin, L
    Serafini, P
    Sylla, B
    Zollo, M
    Franco, B
    Bolino, A
    Seri, M
    Lanyi, A
    Davis, JR
    Webster, D
    Harris, A
    Lenoir, G
    St Basile, GD
    Jones, A
    Behloradsky, BH
    Achatz, H
    Murken, J
    Fassler, R
    Sumegi, J
    Romeo, G
    Vaudin, M
    Ross, MT
    Meindl, A
    Bentley, DR
    [J]. NATURE GENETICS, 1998, 20 (02) : 129 - 135